Weidmann Medical Technology

What Weidmann Medical Technology does

Weidmann Medical Technology AG is a Swiss contract development and manufacturing organization (CDMO) that specializes in high-precision injection molding for the pharmaceutical, diagnostic, and medical device industries. The company operates 86 injection molding presses (15-380 ton clamping range) in ISO Class 7 and 8 cleanrooms, producing over 2 billion diagnostic components and more than 1 billion overmolded needles per year, with end-to-end services spanning product design, tooling, molding, automated assembly, and packaging. Differentiated technical capabilities include proprietary RFID in-mold integration, over 20 years of microfluidics replication expertise, micro and multi-component molding, and 100% in-line vision inspection backed by statistical process control and Six Sigma programs.

The business is structured as a pure CDMO with no own branded products, serving enterprise pharmaceutical, diagnostic, and medical device customers on a quote-based, project-by-project basis under long-term manufacturing contracts. Its manufacturing footprint is anchored in Rapperswil and Bad Ragaz, Switzerland (174 employees, 13,000 m² of medical space), complemented by a 58-employee production site in Saltillo, Mexico, and a US sales office in St Johnsbury. The company is ISO 13485 certified since 2003, FDA-listed to 21 CFR Part 820 since 2013, cGMP-aligned, and ISO 14971 risk-management compliant; in 2025 it received an EcoVadis Silver Medal placing it in the top 10% of companies worldwide for sustainability.

Weidmann Medical is a privately held subsidiary of the Weidmann Group, a Swiss family-owned diversified industrial group with more than 140 years of heritage and 2025 group sales of 573 million CHF across roughly 3,663 employees. The medical business unit employs 232 people and is investing in data acquisition, AI-assisted process optimization, and additional business development capacity in Europe and North America, with no external private equity or venture capital investment disclosed. Revenue at the Weidmann Medical level is not separately reported.

Name

Weidmann Medical Technology

Legal name

Weidmann Medical Technology AG

Website

https://weidmann-medical.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Weidmann Medical Technology AG is a Swiss CDMO providing high-precision cleanroom injection molding and assembly for enterprise pharmaceutical, diagnostic, and medical device customers, operating from Switzerland and Mexico with a US sales office.

Ownership category

akta.pro rank

Product category

Medical Contract Manufacturing

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical Preparation Manufacturing (325412)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Medical injection molding
• Contract manufacturing services
• Pharmaceutical packaging components
• Diagnostic device manufacturing
• Microfluidics production

Headquarters

HQ city

Rapperswil

HQ country

Switzerland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: As a CDMO (Contract Development and Manufacturing Organization), Weidmann Medical generates revenue through long-term manufacturing contracts producing custom injection-molded components for pharmaceutical, diagnostic, and medical device customers. Revenue is driven by production volumes, part complexity, and the scope of services from design through packaging and logistics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Weidmann Medical Technology is a Contract Development and Manufacturing Organization (CDMO) providing end-to-end high-precision injection molding and automated assembly of plastic components for pharmaceutical, diagnostic, and medical device customers. Services span product design and prototyping, tooling, cleanroom injection molding (including micro, multi-component, and insert molding), automated assembly with 100% in-line inspection, project management, and cleanroom packaging and logistics, executed under ISO 13485 and FDA-registered quality systems.

Product overview

Weidmann Medical Technology is a contract development and manufacturing organization (CDMO) providing end-to-end injection molding solutions for the medical, pharmaceutical, and diagnostic industries. The company's core offerings span six interconnected service areas: Product Design and Development (concept to production with DfM/DfA), Injection Molding (cleanroom production with micro, multi-component, and insert molding capabilities), Tooling (partnership-based with predictive maintenance), Automation and Assembly (with 100% in-line inspection), Project Management (digital coordination), and Packaging and Logistics. Specialized capabilities include RFID technology integration for traceability and microfluidics for diagnostics. The company operates across three market segments: Pharma (primary packaging, drug delivery systems), Diagnostics (PCR cartridges, microfluidic components), and Medical Devices (lancing devices, patch pumps).

Differentiator

Problem solved

Functional benefit

Products and services

• Product Design and Development End-to-end engineering services from concept to production, including 3D CAD modeling, feasibility studies, design reviews, design for manufacturing (DfM) and assembly (DfA), prototyping, and risk management documentation (FMEAs). Sold to pharmaceutical, diagnostic, and medical device companies.
• Injection Molding High-precision injection molding services using clamping forces from 150 to 3800 kN, conducted in ISO Class 7 and 8 cleanrooms. Includes micro molding, multi-component molding, insert molding, and microfluidics replication. Sold to enterprise pharmaceutical, diagnostic, and medical device manufacturers.
• Tooling Tooling solutions delivered through industry partnerships with mold makers in Europe, Asia, and the United States, supplemented by in-house repair, maintenance, and predictive maintenance capabilities. Sold as a standalone service to manufacturing customers.
• Automation and Assembly Customized automation concepts and assembly solutions including 100% in-line vision inspection, automated testing, and digital process monitoring in cleanroom environments. Sold to medical device and diagnostic manufacturers.
• Project Management Structured project execution with digital tools ensuring transparency, cross-functional coordination, and risk management from concept through production. Provided to enterprise customers as a contracted service.
• Packaging and Logistics Customized packaging concepts and logistics strategies including cleanroom packaging and labeling, global shipping, and supply chain management for medical and pharmaceutical customers.
• Pharma Solutions Market-focused CDMO offering for the pharmaceutical sector covering primary packaging for plastic containers, drug delivery systems, and pharmaceutical components including luer lock closures, needle shields, syringe closures (tip caps), and safety components for prefilled syringes. Sold to leading pharmaceutical companies.
• Diagnostics Solutions Market-focused CDMO offering for the diagnostics sector producing high-precision components for PCR cartridges, microfluidic systems, point-of-care testing components, and laboratory diagnostics with multi-component molding and strict quality control. Production capacity exceeds 2 billion units per year.
• Medical Devices Solutions Market-focused CDMO offering for medical device manufacturers producing custom-molded components and assemblies including lancing devices, patch pumps, and other advanced devices using multi-component molding, plastics welding, automated assembly lines, and in-line quality control. Over 1 billion needles per year overmolded for the FastClix lancing device.

Quantifiable outcome

• Over 2 billion diagnostic units produced per year
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

Scale indicators12 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• West Pharmaceutical Services: West Pharmaceutical Services is a global leader in primary packaging and delivery components for injectable drugs, including syringe components and stoppers. It is the closest direct peer to Weidmann Medical, particularly in pharma primary packaging and drug delivery sub-assemblies served to leading pharmaceutical manufacturers.
• Stevanato Group: Stevanato Group manufactures pharmaceutical glass primary packaging and integrated drug delivery solutions, with growing plastics injection molding capabilities. Comparable to Weidmann Medical in serving pharma and diagnostic customers with high-precision, high-volume components.
• Gerresheimer: Gerresheimer is a major global manufacturer of pharmaceutical and cosmetic packaging and devices, including high-precision plastic components. It competes with Weidmann Medical across pharma packaging, drug delivery, and medical device sub-assemblies.
• AptarGroup: AptarGroup is a leading supplier of dispensing, sealing, and active material science solutions for pharma, beauty, and food, including drug delivery components and injection molded parts. It is a direct competitor in pharma primary packaging and medical device delivery systems.
• SCHOTT Pharma: SCHOTT Pharma manufactures primary packaging and drug delivery solutions for the pharmaceutical industry, with strong capabilities in syringes and specialty containers. It is comparable to Weidmann Medical in serving leading pharmaceutical customers with high-precision, regulatory-grade components.
• Dätwyler: Dätwyler is a Swiss-based manufacturer of high-precision elastomer and plastic components for pharmaceutical, medical, and automotive applications, with deep regulatory expertise in primary packaging. It is a comparable direct peer to Weidmann Medical in pharma sealing and delivery components.
• Trelleborg Healthcare & Medical: Trelleborg's Healthcare & Medical business manufactures precision-molded polymer components and drug delivery devices for pharmaceutical and medical device customers. It overlaps with Weidmann Medical's silicone and polymer molding capabilities for drug delivery and diagnostic applications.

Broad incumbents

• Becton, Dickinson and Company (BD): BD is a large global medical technology company with extensive injection molding capabilities for medical devices, drug delivery, and diagnostic systems. It serves as a broad incumbent comparable to Weidmann Medical's medical device and diagnostics segments.
• Catalent: Catalent is a large CDMO serving pharmaceutical and biotech customers across biologics, oral solids, sterile injectables, and drug delivery. While Weidmann Medical is more narrowly focused on injection-molded components, Catalent is a relevant broader incumbent in the medical/pharma outsourcing space.

Emerging players

• Spectrum Plastics Group: Spectrum Plastics Group (part of DuPont) specializes in specialty polymer extrusion and injection molding for medical devices and pharmaceutical packaging. It is an emerging specialist competitor in Weidmann Medical's precision plastics CDMO niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/weidmann-medical-technology-ag

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Weidmann Medical Technology